Obesity is known to cause insulin resistance, which is associated with type 2 diabetes and cardiovascular disease4–6, where it has become clear that decreased plasma adiponectin levels in obesity are causally implicated in these obesity-linked diseases7–9. Here, ADIPOQ is linked to type 2 diabetes mellitus.